Cardiology Today Current Issue

The following articles appeared in the print edition of Cardiology Today.

Table of Contents

• Health care industry struggles to keep pace with ‘tectonic shift’ in paid family leave Rob Volansky; Regina Schaffer
• Aspirin ‘benefit may outweigh harm’ in some elevated Lp(a) genotypes Regina Schaffer
• Benefits of aficamten on obstructive HCM symptom burden, QoL sustained at 6 months Scott Buzby
• Breast arterial calcification from mammogram may predict CV risk in women Regina Schaffer
• Califf: US at ‘moment of reckoning’ for heart disease, public health Erik Swain
• Certain contraceptives may increase risk for thrombotic events in women with obesity Scott Buzby
• Contraindications exist between ritonavir/nirmatrelvir and some CV medications Scott Buzby
• Frailty status more predictive of TAVR outcomes than cancer status Regina Schaffer
• HF diagnosis heightens depression, suicide risk in men, women Isabella Hornick
• Pascal noninferior to MitraClip for treatment of degenerative mitral regurgitation Erik Swain
• Pediatric heart transplant waiting times rose during pandemic, but mortality did not Erik Swain
• Pemafibrate lowers triglycerides but not CV events in type 2 diabetes, mixed dyslipidemia Katie Kalvaitis
• Precision testing strategy strongly benefits stable patients with suspected CAD Erik Swain
• Small, single-center study challenges salt restriction during IV diuresis for acute HF Scott Buzby
• Assess CVD risk when considering hormone therapy for menopause symptoms Regina Schaffer
• SPRINT: Benefits of intensive BP lowering may be lost quickly if treatment not sustained Scott Buzby
• Statin plus ezetimibe combination ‘alternative strategy’ to doubled statin dose in ASCVD Regina Schaffer
• Statin therapy ‘vastly superior’ to common dietary supplements for cholesterol lowering Regina Schaffer
• Surgery tops endovascular procedures in CLI, but only if saphenous vein conduit adequate Erik Swain
• Women more likely than men to have adverse events after AF ablation Erik Swain
• Nonsteroidal MRAs: Will finerenone take the throne? Caitlin M. Gibson, PharmD, Med, BCPS, BCCP; Rachel W. Flurie, PharmD, BCPS; Sarah A. Spinler, PharmD, FCCP, FAHA, FASHP, AACC, BCPS (AQ Cardiology)
• APOLLO-B
• BEAGLE
• EchoNet-RCT
• EPIC-STEMI
• INVICTUS
• PROTECTED TAVR
• RADIANCE II
• REDWOOD-HCM-OLE